1Klinik für Kardiologie und Angiologie I, Universitäts-Herzzentrum Freiburg - Bad Krozingen GmbH, Freiburg im Breisgau; 2Institut für Medizinische Biometrie und Statistik, Universitätsklinikum Freiburg, Freiburg im Breisgau; 3Klinik für Herz- und Gefäßchirurgie, Universitäts-Herzzentrum Freiburg - Bad Krozingen GmbH, Freiburg im Breisgau;
|
Background:
Surgical aortic valve replacement (SAVR)
has long been the standard treatment for severe aortic valve stenosis. This study
analyzes the current state of in-hospital mortality and complication rates for
stroke, acute kidney injury (AKI), delirium, and ventilation >48h in the
context of annual hospital case numbers and further influencing factors.
Methods:
All isolated SAVR procedures and
in-hospital outcomes in 2017 were identified by ICD and OPS codes. Hospitals
were divided into 5 volume groups from ≤25 until >100 annual procedures.
Logistic regression analysis was carried out to evaluate risk factors.
Results:
In 2017, 5,533 patients underwent
SAVR in Germany, of these 154 in the lowest volume group. Patients in all
groups had comparable risk (mean logistic EuroSCORE 5.12-4.80%) and age
(66.6-68.1 years). Unadjusted rates of in-hospital mortality as well as
complications were lowest in highest volume group (0.98%; 1.64%; 6.27%; 9.66%;
4.95%). Using centers with ≤25 cases per year as reference, risk-adjusted data
showed a significant inverse volume-outcome relationship for AKI in the highest
volume group (OR=0.53; p=0.036). No significant correlation was seen in
mortality, stroke, and ventilation >48h after risk-adjustment. Significant
risk factors for in-hospital mortality were previous cardiac surgery (OR=5.75,
p<0.001), high grade renal disease with glomerular filtration rate (GFR)
<15ml/min (OR=5.61, p=0.002), surgery in emergency cases (OR=2.71, p=0.002),
higher grade heart failure NYHA III/IV (OR=1.80, p=0.022), and age (OR=1.03,
p=0.031). Risk factors on all four in-hospital complications were atrial fibrillation
and diabetes mellitus. Risk factors on at least one complication were
EuroSCORE, coronary artery disease, and higher grade renal disease. As also
seen in in-hospital mortality, a higher grade heart failure NYHA III/IV was
related to a higher rate of AKI and ventilation >48h, while a lower one
showed a lower rate of ventilation >48h. Also, lower rates of at least one
in-hospital complication were observed in patients with female gender and
previous coronary artery bypass graft.
Conclusion:
Data show that low and high volume
centers have comparably good outcomes in SAVR. While a further high
concentration of operations remains in high volume centers in Germany, small
hospitals are also important in order to ensure sufficient supply with SAVR.
Figure: Outcomes
in SAVR per hospital category in 2017

|